Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century

REFERENCES

• Ahr , H.-J. , Alepee , N. , Breier , S. , Brekelmans , C. , Cotgreave , I. , Gribaldo , L. , Dalnegro , G. , De Silva , O. , Hartung , T. , Lacerda , A. , Leblanc , B. , Lecerf , C. , Linge , J. .P , Luhimies , S , Manou , I. , Maxwell , G. , Müller , K. K. , Pape , W. , Redhead , K. , Schröder , K. R. , Sladowski , D. , van der Jagt , K. and Vanparys , P. 2008 . Barriers to validation. A report by European Partnership for Alternative Approaches to animal testing (EPAA) working group 5 . ATLA , 36 : 459 – 464 .
   Google Scholar
• Andersen , M. E. and Krewski , D. 2009 . Toxicity testing in the 21st century: bringing the vision to life . Toxicol. Sci. , 107 : 324 – 330 .
   PubMed Web of Science ®Google Scholar
• Bhogal , N. , Grindon , C. , Combes , R. and Balls , M. 2005 . Toxicity testing: creating a revolution based on new technologies . Trends Biotechnol. , 23 : 299 – 307 .
   PubMed Web of Science ®Google Scholar
• Balls , M. 2005 . The three Rs: Looking back … and forward . ALTEX , 22 : 227 – 231 .
   PubMedGoogle Scholar
• Barton , H. A. , Chiu , W. A. , Woodrow Setzer , R. , Andersen , M. E. , Bailer , A. J. , Bois , F. Y. , Dewoskin , R. S. , Hays , S. , Johanson , G. , Jones , N. , Loizou , G. , Macphail , R. C. , Portier , C. J. , Spendiff , M. and Tan , Y. M. 2007 . Characterizing uncertainty and variability in physiologically based pharmacokinetic models: State of the science and needs for research and implementation . Toxicol. Sci. , 99 : 395 – 402 .
   PubMed Web of Science ®Google Scholar
• Blaauboer , B. J. and Andersen , M. E. 2007 . The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative . Arch. Toxicol. , 81 : 385 – 387 .
   PubMed Web of Science ®Google Scholar
• Bottini , A. A. and Hartung , T. 2009 . Food for thought … on economics of animal testing . ALTEX , 26 : 3 – 16 .
   PubMedGoogle Scholar
• Bottini , A. A. , Alepee , N. , De Silva , O. , Hartung , T. , Hendriksen , C. , Kuil , J. , Pazos , P. , Philips , B. , Rhein , C. , Schiffelers , M.-J. , Stokes , W. , Theobald , A. , Vidal , J.-M. , Van de Sandt , H. and Blaauboer , B. 2008 . Optimization of the post-validation process. The report and recommendations of ECVAM workshop 67 . Altern. Lab. Animal. , 36 : 353 – 366 .
   PubMedGoogle Scholar
• Bottini , A. A. , Amcoff , P. and Hartung , T. 2007 . Food for thought … on globalization of alternative methods . ALTEX , 24 : 255 – 61 .
   PubMedGoogle Scholar
• Bremer , S. , Pellizzer , C. , Hoffmann , S. , Seidle , T. and Hartung , T. 2007 . The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programs . Curr. Pharm. Design. , 13 : 3047 – 3058 .
   PubMedGoogle Scholar
• Bremer , S. and Hartung , T. 2004 . The use of embryonic stem cells for regulatory developmental toxicity testing in vitro—The current status of test development . Curr. Pharm. Design. , 10 : 2733 – 2747 .
   PubMed Web of Science ®Google Scholar
• Chiu , W. A. , Barton , H. A. , DeWoskin , R. S. , Schlosser , P. , Thompson , C. M. , Sonawane , B. , Lipscomb , J. C.. and Krishnan , K. 2007 . Evaluation of physiologically based pharmacokinetic models for use in risk assessment . J. Appl. Toxicol. , 27 : 218 – 237 .
   PubMed Web of Science ®Google Scholar
• Clewell , R. A. and Clewell , H. J. 3rd . 2008 . Development and specification of physiologically based pharmacokinetic models for use in risk assessment . Regil. Toxicol. Pharmacol. , 50 : 129 – 143 .
   PubMed Web of Science ®Google Scholar
• Coecke , S. , Goldberg , A. M. , Allen , S. , Buzanska , L. , Calamandrei , G. , Crofton , K. , Hareng , L. , Hartung , T. , Knaut , H. , Honegger , P. , Jacobs , M. , Lein , P. , Li , A. , Mundy , W. , Owen , D. , Schneider , S. , Silbergeld , E. , Reum , T. , Trnovec , T. , Monnet-Tschudi , F. and Bal-Price , A. 2007 . Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies . Environ. Health Perspect. , 115 : 924 – 931 .
   PubMed Web of Science ®Google Scholar
• Coecke , S. , Balls , M. , Bowe , G. , Davis , J. , Gstraunthaler , G. , Hartung , T. , Hay , R. , Merten , O.-W. , Price , A. , Schechtman , L. , Stacey , G. and Stokes , W. 2005 . Guidance on Good Cell Culture Practice . ATLA—Altern. Lab. Anim. , 33 : 261 – 287 .
   PubMed Web of Science ®Google Scholar
• Collins , F. S. , Gray , G. M. and Bucher , J. R. 1008 . Toxicology: Transforming environmental health protection . Science , 319 : 906 – 907 .
   Google Scholar
• Combes , R. D. , Berridge , T. , Connelly , J. , Eve , M. D. , Garner , R. C. , Toon , S. and Wilcox , P. 2003 . Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing . Eur. J. Pharmacol. Sci. , 19 : 1 – 11 .
   PubMed Web of Science ®Google Scholar
• Corvi , R. , Ahr , H.-J. , Albertini , S. , Blakey , D. H. , Clerici , L. , Coecke , S. , Douglas , G. R. , Gribaldo , L. , Groten , J. P. , Haase , B. , Hamernik , K. , Hartung , T. , Inoue , T. , Indans , I. , Maurici , D. , Orphanides , G. , Rembges , D. , Sansone , S.-A. , Snape , J. R. , Toda , E. , Tong , W. , van Delft , J. H. , Weis , B. and Schechtman , L. M. 2006 . Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use . Environ. Health Perspect. , 114 : 420 – 429 .
   PubMed Web of Science ®Google Scholar
• Collins , F. S. , Gray , G. M. and Bucher , J. R. 2008 . Toxicology: Transforming environmental health protection . Science , 319 : 906 – 907 .
   PubMed Web of Science ®Google Scholar
• Devolder , T. , Reid , K. , Rogiers , V. , Webb , S. and Wilkins , D. 2008 . A review of national public funding programmes in European countries . ALTEX , 25 : 233 – 242 .
   PubMedGoogle Scholar
• Eskes , C. and Zuang , V. 2005 . Alternative (nonanimal) methods for cosmetic testing: current status and future prospects. A report prepared in the context of the 7th Amendment of the Cosmetic Directive for establishing timetables for phasing out animal testing . ATLA—Altern. Lab. Animal. , 33 ( suppl 1 ) : 1 – 228 .
   PubMedGoogle Scholar
• European Commission. 2007. Fifth Report from the Commission to the Council and the European Parliament on the Statistics on the number of animals used for experimental and other scientific purposes in the member states of the European Union COM/2007/675 final http://ec.europa.eu/environment/chemicals/lab_animals/reports_en.htm
   Google Scholar
• Gibb , S. 2008 . A review of the National Research Council report Toxicity testing in the 21st century: A vision and a strategy . Reprod. Toxicol. , 25 : 136 – 138 .
   PubMedGoogle Scholar
• Greim , H. , Arand , M. , Autrup , H. , Bolt , H. M. , Bridges , J. , Dybing , E. , Glomot , R. , Foa , V. and Schulte-Hermann , R. 2006 . Toxicological comments to the discussion about REACH . Arch. Toxicol. , 80 : 121 – 124 .
   PubMed Web of Science ®Google Scholar
• Griesinger , C. , Hoffmann , S. , Kinsner-Ovaskainen , A. , Coecke , S. and Hartung , T. Proceedings of the First International Forum Towards Evidence-Based Toxicology . Conference Centre Spazio Villa Erba . October 15–18 2007 , Como, Italy. Hum. Exp. Toxicol. 2008 Special Issue: Evidence-Based Toxicology (EBT) 28:81–163
   Google Scholar
• Grindon , C. , Combes , R. , Cronin , M. T. , Roberts , D. W. and Garrod , J. 2006 . A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH—A summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME . ATLA—Altern. Lab. Anim. , 34 ( suppl. 1 ) : 149 – 158 .
   PubMedGoogle Scholar
• Gruber , F. P. and Hartung , T. 2004 . Alternatives to animal experimentation in basic research . ALTEX , 21 ( suppl. 1 ) : 3 – 31 .
   PubMed Web of Science ®Google Scholar
• Hareng , L. , Pellizzer , C. , Bremer , S. , Schwarz , M. and Hartung , T. 2005 . The Integrated Project ReProTect: A novel approach in reproductive toxicity hazard assessment . Reprod. Toxicol. , 20 : 441 – 452 .
   PubMedGoogle Scholar
• Hartung , T. 2007a . Food for thought … on validation . ALTEX , 24 : 67 – 72 .
   PubMed Web of Science ®Google Scholar
• Hartung , T. 2007b . Food for thought … on cell culture . ALTEX , 24 : 143 – 147 .
   PubMedGoogle Scholar
• Hartung , T. 2008a . Food for thought … on animal tests . ALTEX , 25 : 3 – 9 .
   PubMedGoogle Scholar
• Hartung , T. 2008b . Food for thought … on alternative methods for cosmetics safety testing . ALTEX , 25 : 147 – 162 .
   PubMedGoogle Scholar
• Hartung , T. 2008c . Towards a new toxicology—evolution or revolution? . ATLA—Altern. Lab. Anim , 36 : 635 – 639 .
   PubMedGoogle Scholar
• Hartung , T. 2009a . Toxicology for the twenty-first century . Nature , 460 : 208 – 212 .
   PubMed Web of Science ®Google Scholar
• Hartung , T. 2009b . A toxicology for the 21st century: Mapping the road ahead . Toxicol. Sci. , 109 : 18 – 23 .
   PubMed Web of Science ®Google Scholar
• Hartung , T. 2009c . Food for thought… on evidence-based toxicology . ALTEX , 26 : 75 – 82 .
   PubMedGoogle Scholar
• Hartung , T. and Daston , G. 2009 . Are in vitro tests suitable for regulatory use? . Toxicol. Sci , 111 : 233 – 237 .
   PubMed Web of Science ®Google Scholar
• Hartung , T. and Hoffmann , S. 2009 . Food for thought on… . in silico methods in toxicology . ALTEX , 26 : 155 – 166 .
   PubMedGoogle Scholar
• Hartung , T. and Koeter , H. 2008 . Food for thought … on alternative methods for food safety testing . ALTEX , 25 : 259 – 264 .
   PubMedGoogle Scholar
• Hartung , T. and Leist , M. 2008 . Food for thought … on the evolution of toxicology and phasing out of animal testing . ALTEX , 25 : 91 – 96 .
   PubMedGoogle Scholar
• Hartung , T. and Rovida , C. 2009 . Chemical regulators have overreached . Nature , 460 : 1080 – 1081 .
   PubMed Web of Science ®Google Scholar
• Hartung , T. , Bremer , S. , Casati , S. , Coecke , S. , Corvi , R. , Fortaner , S. , Gribaldo , L. , Halder , M. , Hoffmann , S. , Roi , A. J. , Prieto , P. , Sabbioni , E. , Scott , L. , Worth , A. and Zuang , V. 2004 . A modular approach to the ECVAM principles on test validity . ATLA—Altern. Lab. Anim. , 32 : 467 – 472 .
   PubMed Web of Science ®Google Scholar
• Hartung , T. , Bremer , S. , Casati , S. , Coecke , S. , Corvi , R. , Fortaner , S. , Gribaldo , L. , Halder , M. , Roi , A. J. , Prieto , P. , Sabbioni , E. , Worth , A. and Zuang , V. 2003 . ECVAM's response to the changing political environment for alternatives: Consequences of the European Union chemicals and cosmetics policy . ATLA—Altern. Lab Anim. , 31 : 473 – 481 .
   PubMedGoogle Scholar
• Hoffmann , S. and Hartung , T. 2005 . Diagnosis: Toxic!—Trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations . Toxicol. Sci. , 85 : 422 – 428 .
   PubMed Web of Science ®Google Scholar
• Hoffmann , S. and Hartung , T. 2006 . Towards an evidence-based toxicology . Human Exp. Toxicol , 25 : 497 – 513 .
   PubMed Web of Science ®Google Scholar
• Hoffmann , S. , Edler , L. , Gardner , I. , Gribaldo , L. , Hartung , T. , Klein , C. , Liebsch , M. , Sauerland , S. , Schechtman , L. , Stammati , A. and Nikolaidis , E. 2008 . Points of reference in validation—The report and recommendations of ECVAM Workshop . ATLA—Altern. Lab. Anim. , 36 : 343 – 352 .
   PubMedGoogle Scholar
• Hudson , M. 2007 . Why do the numbers of laboratory animal procedures conducted continue to rise? An analysis of the Home Office Statistics of Scientific Procedures on Living Animals: Great Britain 2005 . ATLA—Altern. Lab. Anim. , 35 : 177 – 187 .
   PubMedGoogle Scholar
• Kavlock , R. J. 2009 . The future of toxicity testing-The NRC vision and the EPA's ToxCast program national center for computational toxicology . Neurotoxicol. Teratol. , 31 : 237
   Google Scholar
• Kavlock , R. J. , Austin , C. P. and Tice , R. R. 2009 . Commentary—Toxicity testing in the 21st century: Implications for human health risk assessment . Risk Anal. , 29 : 485 – 487 .
   PubMed Web of Science ®Google Scholar
• Latour , B. and Woolgar , S. 1986 . Laboratory life: The construction of scientific facts , Princeton, NJ : Princeton University Press .
   Google Scholar
• Leist , M. , Hartung , T. and Nicotera , P. 2008 . The dawning of a new age of toxicology . ALTEX , 25 : 103 – 114 .
   PubMedGoogle Scholar
• Leist , M. , Kadereit , S. and Schildknecht , S. 2008 . Food for thought … on the real success of 3R approaches . ALTEX , 25 : 17 – 24 .
   PubMedGoogle Scholar
• National Research Council . 2007 . Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council: Toxicity testing in the 21st century: A vision and a strategy , Washington, DC : National Academies Press .
   Google Scholar
• Pessina , A. , Albella , B. , Bayo , M. , Bueren , J. , Brantom , P. , Casati , S. , Croera , C. , Gagliardi , G. , Foti , P. , Parchment , R. , Parent-Massin , D. , Schoeters , G. , Sibiril , Y. , Van Den Heuvel , R. and Gribaldo , L. 2003 . Application of the CFU-GM assay to predict acute drug-induced neutropenia: An international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics . Toxicol. Sci. , 75 : 355 – 367 .
   PubMed Web of Science ®Google Scholar
• Rovida , C. and Hartung , T. 2009 . Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals . ALTEX , 26 : 187 – 208 .
   PubMed Web of Science ®Google Scholar
• Rudén , C. 2002 . The use of mechanistic data and the handling of scientific uncertainty in carcinogen risk assessments: The trichloroethylene example . Regul. Toxicol. Pharmacol. , 35 : 80 – 94 .
   PubMed Web of Science ®Google Scholar
• Russel, W. M. S., and Burch, R. L. 1959. The principles of humane experimental technique. London: Methuen http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc
   Google Scholar
• Schiffelers , M.-J. W. A. , Blaauboer , B. J. , Martje Fentener van Vlissingen , J. , Kuil , J. , Remie , R. , Thuring , J. W. G. M. , Vaal , M. A. and Hendriksen , C. F. M. 2007 . Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process . ALTEX , 24 : 273 – 278 .
   Google Scholar
• Seidle , T. and Stephens , M. L. 2009 . Bringing toxicology into the 21st century: A global call to action . Toxicol. In Vitro , 23 : 1576 – 1579 .
   PubMed Web of Science ®Google Scholar
• Smith , L. L. 2001 . Key challenges for toxicologists in the 21st century . Trends Pharmacol. Sci. , 22 : 281 – 285 .
   PubMed Web of Science ®Google Scholar
• Stummann , T. C. and Bremer , S. 2008 . The possible impact of human embryonic stem cells on safety pharmacological and toxicological assessments in drug discovery and drug development . Curr. Stem Cell Res. Ther. , 3 : 117 – 130 .
   Google Scholar
• U.S. Environmental Protection Agency. 2009. The U.S. Environmental Protection Agency's strategic plan for evaluating the toxicity of chemicals http://www.epa.gov/osa/spc/toxicitytesting
   Google Scholar
• Vinken , M. , Doktorova , T. , Ellinger-Ziegelbauer , H. , Ahr , H. J. , Lock , E. , Carmichael , P. , Roggen , E. , van Delft , J. , Kleinjans , J. , Castell , J. , Bort , R. , Donato , T. , Ryan , M. , Corvi , R. , Keun , H. , Ebbels , T. , Athersuch , T. , Sansone , S. A. , Rocca-Serra , P. , Stierum , R. , Jennings , P. , Pfaller , W. , Gmuender , H. , Vanhaecke , T. and Rogiers , V. 2008 . The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays . Mutat. Res. , 659 : 202 – 210 .
   PubMed Web of Science ®Google Scholar
• Yang , R. S. , Thomas , R. S. , Gustafson , D. L. , Campain , J. , Benjamin , S. A. , Verhaar , H. J. and Mumtaz , M. M. 1998 . Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling . Environ. Health Perspect. , 106 ( suppl. 6 ) : 1385 – 1393 .
   PubMed Web of Science ®Google Scholar